LIFECORE BIOMEDICAL, INC. Restricted Cash
LIFECORE BIOMEDICAL, INC. (LFCR) had Restricted Cash of $0 as of 2022-05-29, per its 10-K/A filed 2023-03-16.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-03-16
- 2022-05-29: Restricted Cash $0.00.
- 2022-02-27: Restricted Cash $0.00.
- 2021-11-28: Restricted Cash $0.00.
- 2021-08-29: Restricted Cash $0.00.
| Period end | Restricted Cash |
|---|---|
| 2022-05-29 | $0.00 10-K/A · filed 2023-03-16 |
| 2022-02-27 | $0.00 10-Q · filed 2022-04-07 |
| 2021-11-28 | $0.00 10-Q · filed 2022-01-07 |
| 2021-08-29 | $0.00 10-Q · filed 2021-10-05 |
| 2021-05-30 | $0.00 10-K/A · filed 2023-03-16 |
| 2021-02-28 | $0.00 10-Q · filed 2022-04-07 |
| 2020-11-29 | $0.00 10-Q · filed 2022-01-07 |
| 2020-08-30 | $193.00K 10-Q · filed 2021-10-05 |
| 2020-05-31 | $193.00K 10-K/A · filed 2023-03-16 |
| 2020-02-23 | $193.00K 10-Q · filed 2021-04-08 |
| 2019-11-24 | $385.00K 10-Q · filed 2021-01-07 |
| 2019-08-25 | $385.00K 10-Q · filed 2020-10-07 |
| 2019-05-26 | $385.00K 10-K · filed 2021-07-29 |
| 2019-02-24 | $385.00K 10-Q · filed 2020-04-03 |
| 2018-11-25 | $325.00K 10-Q · filed 2020-01-02 |
| 2018-08-26 | $325.00K 10-Q · filed 2018-10-05 |
| 2018-05-27 | $325.00K 10-K · filed 2020-08-14 |
| 2018-02-25 | $325.00K 10-Q · filed 2019-04-04 |
| 2017-11-26 | $325.00K 10-Q · filed 2019-01-07 |
| 2017-08-27 | $325.00K 10-Q · filed 2018-10-05 |
| 2017-05-28 | $325.00K 10-K · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |